Esperion Therapeutics Inc - ESPR - stock price prediction, stock price target, analyst ratings from 8 analysts

Esperion Therapeutics Inc has a share price target of US$ 6, revenue growth forecast of 21.3%, and profit growth estimate of 47.6% for FY25, based on top 8 analyst calls.